Probiotec Overview

  • Founded
  • 1997

Founded
  • Status
  • Public

  • Stock Symbol
  • PBP

Stock Symbol
  • Investments
  • 6

  • Share Price
  • $1.52

  • (As of Friday Closing)

Probiotec General Information

Description

Probiotec Ltd is engaged in manufacturing, marketing, and distributing over-the-counter pharmaceuticals, complementary medicines, and specialty ingredients. It operates through the contract manufacturing segment. It is engaged in manufacture and packing plant producing predominantly pharmaceutical products along with cosmetics and consumer health products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
BPO/Outsource Services
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • 83 Cherry Lane
  • Laverton North, Victoria 3026
  • Australia
+61 (03) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Probiotec Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.52 $1.53 $1.27 - $1.77 $123M 81.3M 29.3K $0.12

Probiotec Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020
EV 174,569 174,569 179,080 120,961
Revenue 132,126 132,126 89,842 71,818
EBITDA 25,113 25,113 14,356 11,051
Net Income 9,933 9,933 3,613 2,349
Total Assets 163,663 163,663 173,466 92,114
Total Debt 63,971 63,971 73,101 26,126
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Probiotec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Probiotec‘s full profile, request access.

Request a free trial

Probiotec Patents

Probiotec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010901715-A0 Pharamceutical compositions Inactive 23-Apr-2010
AU-2010901717-A0 Cold treatment Inactive 23-Apr-2010
AU-2010901718-A0 Eczema treatment Inactive 23-Apr-2010
AU-2011242413-A1 Cold treatment Inactive 23-Apr-2010 000000000
EP-2560677-A4 Cold treatment Inactive 23-Apr-2010 A61K38/40
To view Probiotec’s complete patent history, request access »

Probiotec Executive Team (3)

Name Title Board Seat Contact Info
Wesley Stringer Chief Executive Officer & Executive Director
Jared Stringer Chief Financial Officer & Secretary
Julie McIntosh Chief Operating Officer
To view Probiotec’s complete executive team members history, request access »

Probiotec Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0&0 000000000 01-Aug-2021 0000000000 00.000 Plastic Containers and Packaging
000000000-000 01-Jan-2021 0000000000 000.00 Plastic Containers and Packaging 000000 00
00000000 0000 10-Dec-2019 000000000 00.000 Buildings and Property 000000 00
0000000000 00 31-Jul-2019 0000000000 000.00 Plastic Containers and Packaging 000000 00
85 Cherry Lane (Property) 02-Jul-2018 Corporate Asset Purchase 00.000 Buildings and Property 000000 00
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Probiotec Subsidiaries (4)

Company Name Industry Location Founded
Multipack-LJM Plastic Containers and Packaging Eastern Creek, Australia 1996
00000 0000 0000000 Plastic Containers and Packaging Kirrawee, Australia 0000
0000000000 0000000 Plastic Containers and Packaging Sydney, Australia 0000
0&0 000000000 Plastic Containers and Packaging Sydney, Australia
To view Probiotec’s complete subsidiaries history, request access »